rac 8-Prenylnaringenin structure
|
Common Name | rac 8-Prenylnaringenin | ||
---|---|---|---|---|
CAS Number | 68682-02-0 | Molecular Weight | 340.37000 | |
Density | N/A | Boiling Point | N/A | |
Molecular Formula | C20H20O5 | Melting Point | N/A | |
MSDS | N/A | Flash Point | N/A |
Use of rac 8-Prenylnaringenin(±)-8-Prenylnaringenin, a natural prenylated flavonoid, is a potent phytoestrogen. (±)-8-Prenylnaringenin is an orally active selective estrogen receptor modulator (SERM) (Estrogen Receptor/ERR) that inhibits ERα and ERβ with IC50s of 57 nM and 68 nM, respectively. (±)-8-Prenylnaringenin has anticancer effects, and can be used for osteoporosis research[1][2]. |
Name | rac 8-Prenylnaringenin |
---|---|
Synonym | More Synonyms |
Description | (±)-8-Prenylnaringenin, a natural prenylated flavonoid, is a potent phytoestrogen. (±)-8-Prenylnaringenin is an orally active selective estrogen receptor modulator (SERM) (Estrogen Receptor/ERR) that inhibits ERα and ERβ with IC50s of 57 nM and 68 nM, respectively. (±)-8-Prenylnaringenin has anticancer effects, and can be used for osteoporosis research[1][2]. |
---|---|
Related Catalog | |
Target |
ERα:57 nM (IC50) ERβ:68 nM (IC50) |
In Vitro | 在兔骨髓细胞中,(±)-8-Prenylnaringenin 比 Osteoclasts 更能抑制破骨细胞的形成并诱导破骨细胞凋亡。(±)-8-Prenylnaringenin 应用于 MC3T3-E1 成骨细胞系,可促进分化和成熟,同时抑制 RAW264.7 破骨细胞系的分化。(±)-8-Prenylnaringenin 抑制核因子-κB配体受体激活剂 (RANKL) 的表达,并导致骨保护素的表达增加[1]。 在暴露于 (±)-8-Prenylnaringenin 后,在 PC-3 人前列腺癌细胞和 UO.31 人肾癌细胞中观察到显着的剂量依赖性增殖抑制。在人乳腺癌细胞系 MCF-10A 中,(±)-8-Prenylnaringenin 调节雌二醇转化为促癌代谢物的代谢途径,从而抑制恶性转化[1]。 |
In Vivo | (±)-8-Prenylnaringenin(50 mg/kg;口服强饲法;每天一次;持续 12 天)改善由 STZ 治疗引起的葡萄糖稳态受损和胰岛功能障碍。 (±)-8-Prenylnaringenin 增加胰腺和肝脏中 ERα 和肝脏中成纤维细胞生长因子 21 的蛋白表达水平[3]。 Animal Model: Male C57BL/6J mice (Seven-week-old) injected with Streptozotocin (STZ)[3] Dosage: 50 mg/kg Administration: Orally gavage; once daily; for 12 days Result: Ameliorated impaired glucose homeostasis and islet dysfunction induced by STZ treatment. |
References |
Molecular Formula | C20H20O5 |
---|---|
Molecular Weight | 340.37000 |
Exact Mass | 340.13100 |
PSA | 86.99000 |
LogP | 4.01860 |
Appearance of Characters | Light yellow powder |
Storage condition | −20°C |
Safety Phrases | 22-24/25 |
---|---|
WGK Germany | 3 |
5,7-dihydroxy-2-(4-hydroxyphenyl)-8-(3-methylbut-2-enyl)-2,3-dihydrochromen-4-one |